The weight loss drug Wegovy lowered heart attack risk in a large trial

Meghan Rosen is a staff writer who reports on the life sciences for Science News. She earned a Ph.D. in biochemistry and molecular biology with an emphasis in biotechnology from the University of California, Davis, and later graduated from the science communication program at UC Santa Cruz.

Leave a Reply

Your email address will not be published. Required fields are marked *